Lindbrook Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,671
| Closed | -$193K | – | 2884 |
|
|
2023
Q3 | $193K | Sell |
1,671
-2
| -0.1% | -$231 | 0.02% | 323 |
|
|
2023
Q2 | $172K | Sell |
1,673
-27
| -2% | -$2.78K | 0.02% | 365 |
|
|
2023
Q1 | $186K | Sell |
1,700
-5,113
| -75% | -$558K | 0.02% | 331 |
|
|
2022
Q4 | $775K | Buy |
6,813
+70
| +1% | +$7.97K | 0.1% | 135 |
|
|
2022
Q3 | $417K | Sell |
6,743
-58
| -0.9% | -$3.59K | 0.07% | 169 |
|
|
2022
Q2 | $542K | Buy |
6,801
+8
| +0.1% | +$638 | 0.09% | 138 |
|
|
2022
Q1 | $715K | Sell |
6,793
-6
| -0.1% | -$632 | 0.11% | 117 |
|
|
2021
Q4 | $733K | Buy |
6,799
+5,811
| +588% | +$626K | 0.11% | 117 |
|
|
2021
Q3 | $108K | Buy |
988
+226
| +30% | +$24.7K | 0.03% | 254 |
|
|
2021
Q2 | $71K | Sell |
762
-200
| -21% | -$18.6K | 0.02% | 371 |
|
|
2021
Q1 | $89K | Sell |
962
-554
| -37% | -$51.3K | 0.02% | 299 |
|
|
2020
Q4 | $111K | Buy |
1,516
+536
| +55% | +$39.2K | 0.03% | 228 |
|
|
2020
Q3 | $76K | Buy |
980
+808
| +470% | +$62.7K | 0.02% | 260 |
|
|
2020
Q2 | $10K | Sell |
172
-34
| -17% | -$1.98K | ﹤0.01% | 852 |
|
|
2020
Q1 | $6K | Sell |
206
-794
| -79% | -$23.1K | ﹤0.01% | 963 |
|
|
2019
Q4 | $36K | Hold |
1,000
| – | – | 0.01% | 550 |
|
|
2019
Q3 | $27K | Hold |
1,000
| – | – | 0.01% | 621 |
|
|
2019
Q2 | $24K | Hold |
1,000
| – | – | 0.01% | 639 |
|
|
2019
Q1 | $26K | Hold |
1,000
| – | – | 0.01% | 613 |
|
|
2018
Q4 | $19K | Buy |
+1,000
| New | +$19K | 0.01% | 639 |
|